NYSE · Healthcare
Castellum, Inc. (CTM)
As-reported financials and recent SEC filings for Castellum, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$52.9M
Net income
$-2.4M
Net margin
-4.5%
Diluted EPS
$-0.03
ROE
-6.7%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2022 |
|---|---|---|---|---|---|
| Revenue | $52.9M | $44.8M | $45.2M | $42.2M | $25.1M |
| Gross profit | $19.4M | $18.3M | $18.7M | $17.6M | $11.1M |
| Operating income | $-2.8M | $-7.2M | $-16.7M | $-10.0M | $-7.7M |
| Net income | $-2.4M | $-10.0M | $-17.8M | $-14.9M | $-7.5M |
| Diluted EPS | $-0.03 | $-0.18 | $-0.38 | $-0.55 | $-0.41 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-07-02
View on EDGAR →42026-07-02
View on EDGAR →42026-07-02
View on EDGAR →42026-07-02
View on EDGAR →8-K2026-07-02
View on EDGAR →8-K2026-06-24
View on EDGAR →8-K2026-06-15
View on EDGAR →S-82026-06-01
View on EDGAR →Largest Healthcare peers
Go deeper on CTM
Search Castellum, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.